US RAC PRACTICE EXAM 2024-2025 /COMPLETE QUESTIONS AND CORRECT ANSWERS (100% CORRECT ANSWERS ) A GRADED. [Q]Which meeting is held with the FDA for the purpose of reaching concurrence on the key parameters of the investigational plan for a Class III device? [A] Agreement meeting [B] Determination meeting [C] Presubmission meeting [D] PMA Day-100 meeting - ANSWER-[A] Agreement meeting [Q]Which meeting held with the FDA is necessary for an otherwise stalled drug product development program to proceed? [A] Type A [B] Type B [C] Type C [D] Type D - ANSWER-[A] Type A [Q]Which type of meeting is held with the FDA for a Special Protocol Assessment? [A] Type A [B] Type B [C] Type C [D] Type D - ANSWER-[A] Type A[Q]Within how many days after FDA's receipt of a written request for a meeting should the following meetings occur: Type A, Type B, Type C [A] 15, 30, 45 [B] 30, 45, 60 [C] 30, 60, 90 [D] 30, 60, 75 - ANSWER-[D] 30, 60, 75 [Q]How often does a drug product listing need to occur? [A] Annually [B] Every June and December [C] Quarterly [D] Once - ANSWER-[B] Every June and December [Q]Upon receipt of a complete